Company profile: Devax
1.1 - Company Overview
Company description
- Provider of medical devices.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Devax
Cardiovascular Systems
HQ: United States
Website
- Description: Provider of medical devices for treating peripheral and coronary vascular disease, focusing on plaque removal via orbital atherectomy systems (Diamondback 360 Peripheral and Coronary OAS, Stealth 360), as well as guide wires (ViperWire Advance, Shepherd) and support catheters (ViperCross), helping physicians address difficult disease states, including calcium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiovascular Systems company profile →
CircuLite
HQ: United States
Website
- Description: Provider of minimally-invasive micro-pumps for long-term partial circulatory support to treat chronic heart failure, supplementing a patient's native pumping capacity and enabling a proactive, lower-risk treatment approach.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CircuLite company profile →
Pathway Medical
HQ: United States
Website
- Description: Provider of medical devices for the treatment of arterial and vascular diseases, designing, developing, manufacturing, and marketing these devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pathway Medical company profile →
Applied Therapeutics
HQ: United States
Website
- Description: Provider of drug development targeting molecules/pathways in fatal or debilitating diseases, with programs: govorestat for Galactosemia (pediatric Phase 3 completed; MAA validated; NDA accepted; PDUFA date set), SORD Deficiency (positive pilot; ongoing Phase 3), PMM2-CDG (Phase 2-ready; Expanded Access), AT-001 for Diabetic Cardiomyopathy/Peripheral Neuropathy (Phase 3), and AT-003 for Diabetic Retinopathy (Phase 1-ready).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Therapeutics company profile →
CryoTherapeutics
HQ: Belgium
Website
- Description: Provider of a proprietary intracoronary cryotherapy system (CTS) for the treatment of coronary artery disease, designed to stabilize high-risk plaque lesions and potentially prevent heart attacks without leaving a stent. Offerings include a patented catheter and console interface for localized cryoenergy delivery, and ongoing clinical trials, including the POLARSTAR study, to demonstrate safety and efficacy for regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CryoTherapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Devax
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Devax
2.2 - Growth funds investing in similar companies to Devax
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Devax
4.2 - Public trading comparable groups for Devax
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →